跳至主要内容
临床试验/ACTRN12622001386729
ACTRN12622001386729招募中未知

Clinical Trial assessing the safety and feasibility of performing robotic-assisted multivisceral complete soft tissue extended resections (CSTER) in adults with advanced or recurrent abdominal tumours.

Sydney Local Health District0 个研究点目标入组 20 人开始时间: 2022年10月28日最近更新:

试验速览

阶段
未知
状态
招募中
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 1. Adults aged 18 years or older
  • 2. Cognitively able to give written informed consent for participation
  • 3. Patients who have one of the following pathologies, and who are deemed by the Pelvic Exenteration MDT as being suitable for robotic multivisceral complete soft tissue extended resection:
  • a. Primary pelvic malignancy
  • b. Locally recurrent cancer of the central compartment
  • c. Colovesical, rectourethral or rectovaginal fistulae
  • 4. Elective procedures

排除标准

  • 1. Patients unable or unwilling to undergo pre and post-operative evaluation as per the study protocol
  • 2. Patient and/or disease factors precluding robotic assisted multivisceral soft tissue extended resections such as:
  • a. Previous multiple complex abdominal surgeries
  • b. Bony resection required as part of the extended resection
  • c. Vascular reconstruction required as part of the extended resection
  • d. Other factors as determined by the treating surgeon or Pelvic Exenteration MDT

研究者

相似试验